BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/22/2023 11:20:34 AM | Browse: 188 | Download: 539
 |
Received |
|
2022-10-27 06:03 |
 |
Peer-Review Started |
|
2022-10-27 06:07 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2022-12-31 06:40 |
 |
Revised |
|
2023-01-17 07:01 |
 |
Second Decision |
|
2023-03-03 03:22 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2023-03-03 09:01 |
 |
Articles in Press |
|
2023-03-03 09:01 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-03-07 00:51 |
 |
Publish the Manuscript Online |
|
2023-03-22 11:20 |
ISSN |
1948-5182 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Nanoscience & Nanotechnology |
Manuscript Type |
Basic Study |
Article Title |
mRNA transcriptome profiling of human hepatocellular carcinoma cells HepG2 treated with Catharanthus roseus-silver nanoparticles
|
Manuscript Source |
Invited Manuscript |
All Author List |
Nur Asna Azhar, Siti Aishah Abu Bakar, Marimuthu Citartan and Nor Hazwani Ahmad |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Ministry of Higher Education Malaysia |
FRGS/1/2015/SG03/USM/03/1 |
|
Corresponding Author |
Nor Hazwani Ahmad, PhD, Senior Lecturer, Department of Biomedical Science, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Jalan Tun Hamdan Sheikh Tahir, Kepala Batas 13200, Pulau Pinang, Malaysia. norhazwani@usm.my |
Key Words |
Catharanthus roseus; HepG2; Silver nanoparticles; Transcriptome; oxidative stress; Apoptosis; Cell cycle |
Core Tip |
Despite the increased attention on cancer nanomedicine which is advantageous to overcome the limitations of conventional cancer treatment, the information on the selectivity and detailed mechanisms at the cellular and molecular level remain unclear. To evaluate its selectivity effects, the proliferative activity of both liver cancer cells HepG2 and normal liver cells THLE-3 in response to Catharanthus roseus-silver nanoparticles (C. roseus-AgNPs) was assessed. To determine the possible signalling pathways induced by the C. roseus-AgNPs, the mRNA transcriptome profiling of hepatocellular carcinoma cell line HepG2 was performed, highlighting the expression of genes associated with oxidative stress, apoptosis, and cell cycle arrest. The elucidation of its selectivity effects and detailed wide genome screening would enlighten the cellular and molecular signalling pathways and provide a strong basis towards the development of C. roseus-AgNPs as an anticancer drug for liver cancer. |
Publish Date |
2023-03-22 11:20 |
Citation |
Azhar NA, Abu Bakar SA, Citartan M, Ahmad NH. mRNA transcriptome profiling of human hepatocellular carcinoma cells HepG2 treated with Catharanthus roseus-silver nanoparticles. World J Hepatol 2023; 15(3): 393-409 |
URL |
https://www.wjgnet.com/1948-5182/full/v15/i3/393.htm |
DOI |
https://dx.doi.org/10.4254/wjh.v15.i3.393 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345